CBD plays a major role in the immune system modulation which basically means that it helps in auto-immune conditions such as rheumatoid arthritis. Rheumatoid arthritis is a chronic progressive disease which causes inflammation in joints, resulting in painful deformity, and at times immobility in the fingers, feet, wrists, and ankles. Because to it’s anti inflammatory effects, CBD oil provides relief of joint pain caused by rheumatoid arthritis, and can also decrease joint destruction.
CBD is readily obtainable in most parts of the United States, though its exact legal status is in flux. All 50 states have laws legalizing CBD with varying degrees of restriction, and while the federal government still considers CBD in the same class as marijuana, it doesn’t habitually enforce against it. In December 2015, the FDA eased the regulatory requirements to allow researchers to conduct CBD trials. Currently, many people obtain CBD online without a medical cannabis license. The government’s position on CBD is confusing, and depends in part on whether the CBD comes from hemp or marijuana. The legality of CBD is expected to change, as there is currently bipartisan consensus in Congress to make the hemp crop legal which would, for all intents and purposes, make CBD difficult to prohibit.
CBD oil has numerous proven health benefits. Whether you’re looking to treat your anxiety, depression, chronic pain, insomnia, or just want to feel more focused and relaxed; then CBD oil (or gummies, dabs, or a pre-filled vape pen) is the perfect choice. They even make CBD dog treats so your furry friend can get the benefits. This CBD stuff is the real deal.
Multiple sclerosis (MS). A prescription-only nasal spray product (Sativex, GW Pharmaceuticals) containing both 9-delta-tetrahydrocannabinol (THC) and cannabidiol has been shown to be effective for improving pain, muscle-tightness, and urination frequency in people with MS. This product is used in over 25 countries outside of the United States. But there is inconsistent evidence on the effectiveness of cannabidiol for symptoms of multiple sclerosis when it is used alone. Some early research suggests that using a cannabidiol spray under the tongue might improve pain and muscle tightness, but not muscle spasms, tiredness, bladder control, mobility, or well-being and quality of life in patients with MS.
Love Hemp started its journey very early and is considered today one of the British Pioneers in quality CBD oil products. Schoolmates Tom Rowland and Tony Calamita were the brave founders of Love Hemp Ltd., which has kept growing and thriving non-stop since 2015. Despite the many initial setbacks they encountered and because they believed Cannabidiol is a true “life changer”, Tom and Tony persevered to turn Love Hemp into one of the top brands in the UK market. In our eyes, Love Hemp is indeed the top British brand.
In fact, CBD is therapeutic in nature, and will work to manipulate bodily systems at the cellular level to return afflicted organ systems, tissue systems, and even chemical systems in the central nervous system back to a state of health and homeostasis. This is precisely why it has been capable of treating conditions such as depression and anxiety, to chronic physical ailments such as pain, inflammation, arthritis, and more.

Another field in which CBD is creating a buzz is in the area of mood disorders like anxiety and depression. Both conditions have been treated with a variety of medications, courtesy of Big Pharma, that have had varying levels of success. Again, the long list of side effects can be off-putting to someone who just wants to get through the day without the sweaty tension of anxiety or the gray haze of depression.
More human studies are needed to fully understand the range of risks and side effects that CBD oil may cause. Studies of CBD oil aren’t common. This is partially because Schedule 1 substances like cannabis are highly regulated, causing some obstacles for researchers. With the legalization of marijuana products, more research is possible, and more answers will come.

Statement from FDA Commissioner Scot Gottlieb, M.D., on signing of the Agriculture Improvement Act and the agency's regulation of products containing cannabis and cannabis-derived compounds. U.S. Food and Drug Administration Web site. Available at: https://www.fda.gov/news-events/press-announcements/statement-fda-commissioner-scott-gottlieb-md-signing-agriculture-improvement-act-and-agencys. (Accessed May 7, 2019).
We use cookies and similar technologies to improve your browsing experience, personalize content and offers, show targeted ads, analyze traffic, and better understand you. We may share your information with third-party partners for marketing purposes. To learn more and make choices about data use, visit our Advertising Policy and Privacy Policy. By clicking “Accept and Continue” below, (1) you consent to these activities unless and until you withdraw your consent using our rights request form, and (2) you consent to allow your data to be transferred, processed, and stored in the United States.
×